ClinicalTrials.Veeva

Menu
I

Instituto San Marcos | San Juan, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
MK-3475
Tamoxifen
Anastrozole
Exemestane
Imlunestrant
MK-3475-587
MK-3475-859
Letrozole
Abemaciclib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 7 total trials

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer (EMBER-4)

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Enrolling
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaci...

Active, not recruiting
Neoplasm Metastasis
Breast Neoplasms
Drug: Imlunestrant
Drug: Abemaciclib

The purpose of this study is to evaluate participant preference for coformulated hyaluronidase/pembrolizumab pembrolizumab (+) berahyaluronidase alfa...

Active, not recruiting
Melanoma
Renal Cell Carcinoma
Biological: Pembrolizumab (+) Berahyaluronidase alfa
Biological: Pembrolizumab

The purpose of this study is to assess the efficacy and safety of pembrolizumab plus lenvatinib plus chemotherapy compared with pembrolizumab plus ch...

Active, not recruiting
Metastatic Esophageal Squamous Cell Carcinoma
Drug: Oxaliplatin
Drug: Levoleucovorin

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizum...

Enrolling
Solid Tumors
Hematologic Malignancies
Drug: Pembrolizumab
Biological: MK-4280A

The safety and efficacy of pembrolizumab plus the investigator's choice of chemotherapy will be assessed compared to placebo plus the investigator's...

Active, not recruiting
Breast Neoplasms
Drug: dextrose
Drug: liposomal doxorubicin

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems